223 related articles for article (PubMed ID: 18178815)
1. ICOS controls the pool size of effector-memory and regulatory T cells.
Burmeister Y; Lischke T; Dahler AC; Mages HW; Lam KP; Coyle AJ; Kroczek RA; Hutloff A
J Immunol; 2008 Jan; 180(2):774-82. PubMed ID: 18178815
[TBL] [Abstract][Full Text] [Related]
2. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
Gotsman I; Grabie N; Gupta R; Dacosta R; MacConmara M; Lederer J; Sukhova G; Witztum JL; Sharpe AH; Lichtman AH
Circulation; 2006 Nov; 114(19):2047-55. PubMed ID: 17060381
[TBL] [Abstract][Full Text] [Related]
3. ICOS contributes to T cell expansion in CTLA-4 deficient mice.
van Berkel ME; Schrijver EH; Hofhuis FM; Sharpe AH; Coyle AJ; Broeren CP; Tesselaar K; Oosterwegel MA
J Immunol; 2005 Jul; 175(1):182-8. PubMed ID: 15972646
[TBL] [Abstract][Full Text] [Related]
4. The role of ICOS in the development of CD4 T cell help and the reactivation of memory T cells.
Mahajan S; Cervera A; MacLeod M; Fillatreau S; Perona-Wright G; Meek S; Smith A; MacDonald A; Gray D
Eur J Immunol; 2007 Jul; 37(7):1796-808. PubMed ID: 17549732
[TBL] [Abstract][Full Text] [Related]
5. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
[TBL] [Abstract][Full Text] [Related]
6. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
[TBL] [Abstract][Full Text] [Related]
7. The ICOS molecule plays a crucial role in the development of mucosal tolerance.
Miyamoto K; Kingsley CI; Zhang X; Jabs C; Izikson L; Sobel RA; Weiner HL; Kuchroo VK; Sharpe AH
J Immunol; 2005 Dec; 175(11):7341-7. PubMed ID: 16301640
[TBL] [Abstract][Full Text] [Related]
8. Aberrant ICOS
Kälble F; Mai C; Wagner M; Schober L; Schaier M; Zeier M; Spratte J; Fluhr H; Steinborn A
Am J Reprod Immunol; 2016 Nov; 76(5):415-425. PubMed ID: 27650411
[TBL] [Abstract][Full Text] [Related]
9. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory T cells conveying respiratory tolerance.
Busse M; Krech M; Meyer-Bahlburg A; Hennig C; Hansen G
J Immunol; 2012 Aug; 189(4):1975-82. PubMed ID: 22815292
[TBL] [Abstract][Full Text] [Related]
10. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
11. ICOS mediates the development of insulin-dependent diabetes mellitus in nonobese diabetic mice.
Hawiger D; Tran E; Du W; Booth CJ; Wen L; Dong C; Flavell RA
J Immunol; 2008 Mar; 180(5):3140-7. PubMed ID: 18292537
[TBL] [Abstract][Full Text] [Related]
12. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10.
Löhning M; Hutloff A; Kallinich T; Mages HW; Bonhagen K; Radbruch A; Hamelmann E; Kroczek RA
J Exp Med; 2003 Jan; 197(2):181-93. PubMed ID: 12538658
[TBL] [Abstract][Full Text] [Related]
13. Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease.
Tesciuba AG; Subudhi S; Rother RP; Faas SJ; Frantz AM; Elliot D; Weinstock J; Matis LA; Bluestone JA; Sperling AI
J Immunol; 2001 Aug; 167(4):1996-2003. PubMed ID: 11489981
[TBL] [Abstract][Full Text] [Related]
14. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
15. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
[TBL] [Abstract][Full Text] [Related]
16. The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28.
Suh WK; Tafuri A; Berg-Brown NN; Shahinian A; Plyte S; Duncan GS; Okada H; Wakeham A; Odermatt B; Ohashi PS; Mak TW
J Immunol; 2004 May; 172(10):5917-23. PubMed ID: 15128772
[TBL] [Abstract][Full Text] [Related]
17. The regulation of T-cell cytokine production by ICOS-B7H2 interactions at the human fetomaternal interface.
Nagamatsu T; Barrier BF; Schust DJ
Immunol Cell Biol; 2011 Mar; 89(3):417-25. PubMed ID: 20733594
[TBL] [Abstract][Full Text] [Related]
18. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS.
Linterman MA; Rigby RJ; Wong R; Silva D; Withers D; Anderson G; Verma NK; Brink R; Hutloff A; Goodnow CC; Vinuesa CG
Immunity; 2009 Feb; 30(2):228-41. PubMed ID: 19217324
[TBL] [Abstract][Full Text] [Related]
19. IL-6 and ICOS Antagonize Bim and Promote Regulatory T Cell Accrual with Age.
Raynor J; Karns R; Almanan M; Li KP; Divanovic S; Chougnet CA; Hildeman DA
J Immunol; 2015 Aug; 195(3):944-52. PubMed ID: 26109645
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.
Yu XZ; Liang Y; Nurieva RI; Guo F; Anasetti C; Dong C
J Immunol; 2006 Jun; 176(12):7394-401. PubMed ID: 16751384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
